CONSOLIDATED STATEMENTS STOCKHOLDERS’ EQUITY - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Accumulated Other Comprehensive (Loss) Income
Common stock, shares outstanding, beginning balance (in shares) at Dec. 31, 2022		26,553,681
Beginning balance at Dec. 31, 2022	$ 399,150	$ 27	$ 560,409	$ (160,905)	$ (381)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation expense	$ 51,219		51,219
Exercise of common stock options (in shares)	71,525	71,525
Exercise of common stock options	$ 269		269
Issuance of common stock from vested restricted stock units, performance stock units and payment of employees' taxes (in shares)		645,454
Issuance of common stock from vested restricted stock units, performance stock units, net of shares withheld for taxes	(5,134)		(5,134)
Issuance of common stock under the employee stock purchase plan (in shares)		139,872
Issuance of common stock under the employee stock purchase plan	2,714		2,714
Net unrealized gain on marketable investment securities	517				517
Net (loss) income	(57,466)			(57,466)
Common stock, shares outstanding, ending balance (in shares) at Dec. 31, 2023		27,410,532
Ending balance at Dec. 31, 2023	391,269	$ 27	609,477	(218,371)	136
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation expense	$ 50,320		50,320
Exercise of common stock options (in shares)	135,875	135,875
Exercise of common stock options	$ 2,017		2,017
Issuance of common stock from vested restricted stock units, performance stock units and payment of employees' taxes (in shares)		769,100
Issuance of common stock from vested restricted stock units, performance stock units, net of shares withheld for taxes	(8,762)		(8,762)
Issuance of common stock under the employee stock purchase plan (in shares)		167,688
Issuance of common stock under the employee stock purchase plan	2,652	$ 1	2,651
Net unrealized gain on marketable investment securities	94				94
Net (loss) income	$ 18,245			18,245
Common stock, shares outstanding, ending balance (in shares) at Dec. 31, 2024	28,483,195	28,483,195
Ending balance at Dec. 31, 2024	$ 455,835	$ 28	655,703	(200,126)	230
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation expense	$ 45,893		45,893
Exercise of common stock options (in shares)	108,458	108,458
Exercise of common stock options	$ 2,206		2,206
Issuance of common stock from vested restricted stock units, performance stock units and payment of employees' taxes (in shares)		933,763
Issuance of common stock from vested restricted stock units, performance stock units, net of shares withheld for taxes	(11,657)	$ 1	(11,658)
Issuance of common stock under the employee stock purchase plan (in shares)		160,898
Issuance of common stock under the employee stock purchase plan	2,717	$ 1	2,716
Net unrealized gain on marketable investment securities	37				37
Net (loss) income	$ (24,158)			(24,158)
Common stock, shares outstanding, ending balance (in shares) at Dec. 31, 2025	29,686,314	29,686,314
Ending balance at Dec. 31, 2025	$ 470,873	$ 30	$ 694,860	$ (224,284)	$ 267